Pazopanib does not bring remarkable improvement in patients with angiosarcoma

In conclusion, our case series suggests that pazopanib does not bring remarkable improvement in patients with angiosarcoma.

Source: The Journal of Dermatology - August 28, 2016 Category: Dermatology Authors: Shinya Kitamura, Teruki Yanagi, Yuka Inamura, Hiroo Hata, Keisuke Imafuku, Koji Yoshino, Hiroshi Shimizu Tags: Concise Communication Source Type: research